{"id":644,"date":"2022-12-07T17:01:44","date_gmt":"2022-12-07T17:01:44","guid":{"rendered":"https:\/\/zenithpv.ca\/?p=644"},"modified":"2022-12-07T17:01:44","modified_gmt":"2022-12-07T17:01:44","slug":"rapports-de-synthese-annuels-asr-evitant-les-observations-daudit-courantes","status":"publish","type":"post","link":"https:\/\/zenithpv.ca\/fr\/2022\/12\/07\/rapports-de-synthese-annuels-asr-evitant-les-observations-daudit-courantes\/","title":{"rendered":"Rapports de synth\u00e8se annuels (RSA) : \u00e9viter les observations d&#039;audit courantes"},"content":{"rendered":"<p>[rang\u00e9e]<\/p>\n<p>[col span__sm=\u201d12\u2033 class=\u201dpb-0\u2033]<\/p>\n<p>Les probl\u00e8mes li\u00e9s \u00e0 la qualit\u00e9 et \u00e0 l&#039;exactitude des ASR restent la deuxi\u00e8me observation r\u00e9glementaire la plus courante observ\u00e9e en 2021-22, juste apr\u00e8s la d\u00e9claration des effets ind\u00e9sirables graves des m\u00e9dicaments.<sup>1<\/sup>. Les RSA ont repr\u00e9sent\u00e9 20% des observations durant cette p\u00e9riode. Les observations post\u00e9rieures \u00e0 l&#039;inspection des BPV de Sant\u00e9 Canada concernant la gestion et\/ou la pr\u00e9paration des RSA constituent l&#039;une des observations les plus fr\u00e9quemment rapport\u00e9es dans la base de donn\u00e9es des inspections de Sant\u00e9 Canada.<sup>2<\/sup>.<\/p>\n<p><em>Alors que les ASR font l\u2019objet d\u2019une surveillance accrue, comment les titulaires d\u2019autorisations de mise sur le march\u00e9 peuvent-ils \u00e9viter les observations courantes des audits ASR ?<\/em><\/p>\n<p>Les directives contenues dans le document C.01.018 \u00e9tablissent les exigences auxquelles doivent satisfaire les titulaires d&#039;autorisation de mise sur le march\u00e9 canadiens pour pr\u00e9parer et soumettre des rapports de synth\u00e8se sur les m\u00e9dicaments commercialis\u00e9s et les produits de sant\u00e9 naturels sur une base annuelle, conform\u00e9ment aux lignes directrices de Sant\u00e9 Canada.<sup>3<\/sup>.<\/p>\n<p>Les rapports de synth\u00e8se annuels (RSA) doivent fournir un aper\u00e7u du profil avantages-risques des m\u00e9dicaments commercialis\u00e9s ou des produits de sant\u00e9 naturels distribu\u00e9s \u00e0 l\u2019\u00e9chelle mondiale et au Canada dans un intervalle \u00e9tabli apr\u00e8s la commercialisation.<\/p>\n<p>Pour ce faire, les titulaires d&#039;autorisation de mise sur le march\u00e9 doivent examiner toutes les donn\u00e9es d&#039;innocuit\u00e9 disponibles apr\u00e8s la mise sur le march\u00e9, y compris les activit\u00e9s de pharmacovigilance et l&#039;exposition des patients au Canada et \u00e0 l&#039;\u00e9tranger. Cela comprend l&#039;examen des aspects li\u00e9s \u00e0 la strat\u00e9gie de minimisation des risques et l&#039;\u00e9valuation de son efficacit\u00e9.<\/p>\n<p>L&#039;un des probl\u00e8mes les plus fr\u00e9quents des rapports d&#039;\u00e9valuation des risques est l&#039;absence d&#039;une analyse critique d\u00e9taill\u00e9e, d&#039;une \u00e9valuation concise et d&#039;une discussion des donn\u00e9es d&#039;innocuit\u00e9 recueillies au cours de la p\u00e9riode de 12 mois. Sant\u00e9 Canada s&#039;attend \u00e0 ce que ces \u00e9l\u00e9ments permettent aux titulaires d&#039;autorisation de mise sur le march\u00e9 de prendre les d\u00e9cisions appropri\u00e9es et opportunes pour mettre \u00e0 jour les informations d&#039;innocuit\u00e9 du produit, si des probl\u00e8mes graves sont identifi\u00e9s au cours du processus.<\/p>\n<p>Le non-respect de cet objectif principal des rapports de synth\u00e8se et le non-respect des lignes directrices de Sant\u00e9 Canada lors de la pr\u00e9paration et de la soumission de rapports de synth\u00e8se pour les m\u00e9dicaments commercialis\u00e9s et les produits de sant\u00e9 naturels peuvent entra\u00eener une observation d\u2019audit.<\/p>\n<p>Zenith PV Solutions poss\u00e8de une solide exp\u00e9rience de collaboration avec les auditeurs de Sant\u00e9 Canada et de r\u00e9daction de rapports d&#039;audit ind\u00e9pendants (RAI) qui \u00e9vitent les observations courantes. Nous serons ravis de vous accompagner dans vos d\u00e9marches relatives aux RAI, que ce soit pour vous aider \u00e0 r\u00e9pondre aux observations ou pour vous pr\u00e9parer \u00e0 votre prochain audit. Contactez un partenaire Zenith d\u00e8s aujourd&#039;hui au <a href=\"mailto:info@zenithpv.ca\">info@zenithpv.ca<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>R\u00e9f\u00e9rence:<\/p>\n<ul>\n<li>DIA 2022 Ottawa. Donn\u00e9es pr\u00e9sent\u00e9es par Myriam Salem, conseill\u00e8re principale en r\u00e9glementation et en application de la loi \u00e0 Sant\u00e9 Canada.<\/li>\n<li><a href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/inspecting-monitoring-drug-health-products\/drug-health-product-inspections.html\">Base de donn\u00e9es des inspections des m\u00e9dicaments et des produits de sant\u00e9 (BDIPM) \u2013 Canada.ca<\/a><\/li>\n<li><a href=\"https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/reports-publications\/medeffect-canada\/preparing-submitting-summary-reports-marketed-drugs-natural-health-products-guidance-industry.html\">Pr\u00e9paration et pr\u00e9sentation des rapports de synth\u00e8se sur les m\u00e9dicaments et les produits de sant\u00e9 naturels commercialis\u00e9s \u2013 Ligne directrice \u00e0 l&#039;intention de l&#039;industrie \u2013 Canada.ca<\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>[\/col]<\/p>\n<p>[\/rang\u00e9e]<\/p>","protected":false},"excerpt":{"rendered":"<p>L&#039;inspection GVP de Sant\u00e9 Canada est con\u00e7ue pour \u00e9valuer la conformit\u00e9 des titulaires d&#039;autorisations de mise sur le march\u00e9 \u00e9trangers et locaux aux lignes directrices GVP, afin de garantir qu&#039;un syst\u00e8me ad\u00e9quat est en place pour surveiller l&#039;utilisation s\u00fbre et efficace des m\u00e9dicaments.1 \u00c0 ce titre, l&#039;\u00e9valuation de la conformit\u00e9 est essentielle \u00e0 la continuit\u00e9 des soins et \u00e0 l&#039;am\u00e9lioration des patients.<\/p>","protected":false},"author":1,"featured_media":645,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-644","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-articles"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.2 (Yoast SEO v26.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Annual Summary Reports (ASRs): Avoiding the common audit observations - ZenithPV<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/zenithpv.ca\/fr\/2022\/12\/07\/rapports-de-synthese-annuels-asr-evitant-les-observations-daudit-courantes\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Annual Summary Reports (ASRs): Avoiding the common audit observations\" \/>\n<meta property=\"og:description\" content=\"Health Canada GVP inspection is designed to assess compliance of foreign and local MAHs to the GVP guidelines, to ensure an adequate system is in place for monitoring the safe and effective use of medicinal products.1 As such, compliant rating is critical to the continuity of care and betterment of patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/zenithpv.ca\/fr\/2022\/12\/07\/rapports-de-synthese-annuels-asr-evitant-les-observations-daudit-courantes\/\" \/>\n<meta property=\"og:site_name\" content=\"ZenithPV\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-07T17:01:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/12\/7019280-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lloyd\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lloyd\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/\"},\"author\":{\"name\":\"Lloyd\",\"@id\":\"https:\/\/zenithpv.ca\/#\/schema\/person\/c6ffd5788a77ffd2fbc6de6113f041a3\"},\"headline\":\"Annual Summary Reports (ASRs): Avoiding the common audit observations\",\"datePublished\":\"2022-12-07T17:01:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/\"},\"wordCount\":402,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/zenithpv.ca\/#organization\"},\"image\":{\"@id\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/12\/7019280-scaled-1.jpg\",\"articleSection\":[\"Articles\"],\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/\",\"url\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/\",\"name\":\"Annual Summary Reports (ASRs): Avoiding the common audit observations - ZenithPV\",\"isPartOf\":{\"@id\":\"https:\/\/zenithpv.ca\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/12\/7019280-scaled-1.jpg\",\"datePublished\":\"2022-12-07T17:01:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#primaryimage\",\"url\":\"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/12\/7019280-scaled-1.jpg\",\"contentUrl\":\"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/12\/7019280-scaled-1.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/zenithpv.ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Annual Summary Reports (ASRs): Avoiding the common audit observations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/zenithpv.ca\/#website\",\"url\":\"https:\/\/zenithpv.ca\/\",\"name\":\"ZenithPV\",\"description\":\"Specialists In Pharmacovigilance, Canada\",\"publisher\":{\"@id\":\"https:\/\/zenithpv.ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/zenithpv.ca\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/zenithpv.ca\/#organization\",\"name\":\"Zenith PV Solutions Inc.\",\"url\":\"https:\/\/zenithpv.ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/zenithpv.ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/07\/ZenithLogo.png\",\"contentUrl\":\"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/07\/ZenithLogo.png\",\"width\":625,\"height\":125,\"caption\":\"Zenith PV Solutions Inc.\"},\"image\":{\"@id\":\"https:\/\/zenithpv.ca\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/ca.linkedin.com\/company\/zenithpv\",\"https:\/\/www.youtube.com\/channel\/UCvQfRUpb7WdvF3I8PX9pdXA\"],\"description\":\"Zenith PV pride ourself on deep industry knowledge and a network of experts in pharmacovigilance, regulatory affairs, and quality assurance.\",\"email\":\"info@zenithpv.ca\",\"telephone\":\"(416) 807-5441\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"11\",\"maxValue\":\"50\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/zenithpv.ca\/#\/schema\/person\/c6ffd5788a77ffd2fbc6de6113f041a3\",\"name\":\"Lloyd\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/zenithpv.ca\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0d2967ec5152a2bf43a21bd5ceb8e4e2a40dd45c5efe58f731a0cebbdd8bcef9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0d2967ec5152a2bf43a21bd5ceb8e4e2a40dd45c5efe58f731a0cebbdd8bcef9?s=96&d=mm&r=g\",\"caption\":\"Lloyd\"},\"sameAs\":[\"https:\/\/zenithpv.ca\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Rapports de synth\u00e8se annuels (RSA)\u00a0: \u00e9viter les observations d&#039;audit courantes - ZenithPV","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/zenithpv.ca\/fr\/2022\/12\/07\/rapports-de-synthese-annuels-asr-evitant-les-observations-daudit-courantes\/","og_locale":"fr_CA","og_type":"article","og_title":"Annual Summary Reports (ASRs): Avoiding the common audit observations","og_description":"Health Canada GVP inspection is designed to assess compliance of foreign and local MAHs to the GVP guidelines, to ensure an adequate system is in place for monitoring the safe and effective use of medicinal products.1 As such, compliant rating is critical to the continuity of care and betterment of patients.","og_url":"https:\/\/zenithpv.ca\/fr\/2022\/12\/07\/rapports-de-synthese-annuels-asr-evitant-les-observations-daudit-courantes\/","og_site_name":"ZenithPV","article_published_time":"2022-12-07T17:01:44+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/12\/7019280-scaled-1.jpg","type":"image\/jpeg"}],"author":"Lloyd","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Lloyd","Estimation du temps de lecture":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#article","isPartOf":{"@id":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/"},"author":{"name":"Lloyd","@id":"https:\/\/zenithpv.ca\/#\/schema\/person\/c6ffd5788a77ffd2fbc6de6113f041a3"},"headline":"Annual Summary Reports (ASRs): Avoiding the common audit observations","datePublished":"2022-12-07T17:01:44+00:00","mainEntityOfPage":{"@id":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/"},"wordCount":402,"commentCount":0,"publisher":{"@id":"https:\/\/zenithpv.ca\/#organization"},"image":{"@id":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#primaryimage"},"thumbnailUrl":"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/12\/7019280-scaled-1.jpg","articleSection":["Articles"],"inLanguage":"fr-CA","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/","url":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/","name":"Rapports de synth\u00e8se annuels (RSA)\u00a0: \u00e9viter les observations d&#039;audit courantes - ZenithPV","isPartOf":{"@id":"https:\/\/zenithpv.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#primaryimage"},"image":{"@id":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#primaryimage"},"thumbnailUrl":"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/12\/7019280-scaled-1.jpg","datePublished":"2022-12-07T17:01:44+00:00","breadcrumb":{"@id":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#primaryimage","url":"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/12\/7019280-scaled-1.jpg","contentUrl":"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/12\/7019280-scaled-1.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/zenithpv.ca\/2022\/12\/07\/annual-summary-reports-asrs-avoiding-the-common-audit-observations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/zenithpv.ca\/"},{"@type":"ListItem","position":2,"name":"Annual Summary Reports (ASRs): Avoiding the common audit observations"}]},{"@type":"WebSite","@id":"https:\/\/zenithpv.ca\/#website","url":"https:\/\/zenithpv.ca\/","name":"ZenithPV","description":"Sp\u00e9cialistes en pharmacovigilance, Canada","publisher":{"@id":"https:\/\/zenithpv.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/zenithpv.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/zenithpv.ca\/#organization","name":"Zenith PV Solutions Inc.","url":"https:\/\/zenithpv.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/zenithpv.ca\/#\/schema\/logo\/image\/","url":"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/07\/ZenithLogo.png","contentUrl":"https:\/\/zenithpv.ca\/wp-content\/uploads\/2022\/07\/ZenithLogo.png","width":625,"height":125,"caption":"Zenith PV Solutions Inc."},"image":{"@id":"https:\/\/zenithpv.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/ca.linkedin.com\/company\/zenithpv","https:\/\/www.youtube.com\/channel\/UCvQfRUpb7WdvF3I8PX9pdXA"],"description":"Zenith PV est fi\u00e8re de sa connaissance approfondie du secteur et de son r\u00e9seau d&#039;experts en pharmacovigilance, affaires r\u00e9glementaires et assurance qualit\u00e9.","email":"info@zenithpv.ca","telephone":"(416) 807-5441","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"11","maxValue":"50"}},{"@type":"Person","@id":"https:\/\/zenithpv.ca\/#\/schema\/person\/c6ffd5788a77ffd2fbc6de6113f041a3","name":"Lloyd","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/zenithpv.ca\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0d2967ec5152a2bf43a21bd5ceb8e4e2a40dd45c5efe58f731a0cebbdd8bcef9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0d2967ec5152a2bf43a21bd5ceb8e4e2a40dd45c5efe58f731a0cebbdd8bcef9?s=96&d=mm&r=g","caption":"Lloyd"},"sameAs":["https:\/\/zenithpv.ca"]}]}},"_links":{"self":[{"href":"https:\/\/zenithpv.ca\/fr\/wp-json\/wp\/v2\/posts\/644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zenithpv.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zenithpv.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zenithpv.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/zenithpv.ca\/fr\/wp-json\/wp\/v2\/comments?post=644"}],"version-history":[{"count":0,"href":"https:\/\/zenithpv.ca\/fr\/wp-json\/wp\/v2\/posts\/644\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/zenithpv.ca\/fr\/wp-json\/wp\/v2\/media\/645"}],"wp:attachment":[{"href":"https:\/\/zenithpv.ca\/fr\/wp-json\/wp\/v2\/media?parent=644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zenithpv.ca\/fr\/wp-json\/wp\/v2\/categories?post=644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zenithpv.ca\/fr\/wp-json\/wp\/v2\/tags?post=644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}